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Research Article
Assessment and site-speciﬁc manipulation of DNA
(hydroxy-)methylation during mouse corticogenesis
Florian Noack1 , Abhijeet Pataskar2, Martin Schneider3, Frank Buchholz3, Vijay K Tiwari2, Federico Calegari1
Dynamic changes in DNA (hydroxy-)methylation are fundamental
for stem cell differentiation. However, the signature of these
epigenetic marks in speciﬁc cell types during corticogenesis is
unknown. Moreover, site-speciﬁc manipulation of cytosine
modiﬁcations is needed to reveal the signiﬁcance and function of
these changes. Here, we report the ﬁrst assessment of (hydroxy-)
methylation in neural stem cells, neurogenic progenitors, and
newborn neurons during mammalian corticogenesis. We found
that gain in hydroxymethylation and loss in methylation occur
sequentially at speciﬁc cellular transitions during neurogenic
commitment. We also found that these changes predominantly
occur within enhancers of neurogenic genes up-regulated
during neurogenesis and target of pioneer transcription fac-
tors. We further optimized the use of dCas9-Tet1 manipulation
of (hydroxy-)methylation, locus-speciﬁcally, in vivo, showing the
biological relevance of our observations for Dchs1, a regulator of
corticogenesis involved in developmental malformations and
cognitive impairment. Together, our data reveal the dynamics of
cytosine modiﬁcations in lineage-related cell types, whereby
methylation is reduced and hydroxymethylation gained during
the neurogenic lineage concurrently with up-regulation of pi-
oneer transcription factors and activation of enhancers for
neurogenic genes.
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Introduction
During embryonic development of the mammalian brain, neural
stem and progenitor cells progressively switch from proliferative to
differentiative divisions to generate neurons and glia that populate
the cortical layers. This switch ultimately controls cortical thickness
and surface area during development and evolution and is im-
portant for better understanding the molecular cell biology of
somatic stem cells and their potential use in therapy (LaMonica
et al, 2012; Southwell et al, 2014; Taverna et al, 2014). Although it is
increasingly clear that cell fate commitment involves a massive
rewiring of gene expression programs, the epigenetic mechanisms
underlying these changes are yet to be fully understood.
Speciﬁcally, before neurogenesis, radial glial, neural stem cells
populating the ventricular zone (VZ) undergo symmetric, pro-
liferative divisions that exponentially expand their number over
time. With development, an increasing proportion of radial glial
cells switches to asymmetric, differentiative divisions to generate
basal, intermediate progenitors that leave the VZ to form the
subventricular zone (SVZ) (Lui et al, 2011; Taverna et al, 2014). Al-
though the majority (~80%) of basal progenitors are soon consumed
to generate neurons, a subpopulation remains that undergoes a few
rounds of symmetric proliferative divisions to expand their pool
within the SVZ (Lui et al, 2011; Taverna et al, 2014). As a result, both
proliferative progenitors (PPs) and differentiative progenitors (DPs)
coexist as intermingled populations in the two germinal zones of
the mammalian VZ and SVZ, whereas neurons are added to the
cortical layers.
Understanding the switch from proliferation to differentiation of
neural progenitors, thus, requires the identiﬁcation of PP from DP
and neurons. To this end, our group has previously characterized a
double reporter mouse line that allowed the isolation of DP and
neurons by the expression of Btg2RFP and Tubb3GFP, respectively,
and of PP by the lack of both reporters (Aprea et al, 2013). This
approach led to the identiﬁcation of genes transitorily up- or down-
regulated speciﬁcally in DP relative to both PP and neurons and,
thus, identifying the functional signature to neurogenic commit-
ment (Aprea et al, 2015; Aprea et al, 2013; Artegiani et al, 2015; de
Jesus Domingues et al, 2016). To further decipher the regulatory
mechanisms underlying changes in gene expression, we here
decided to characterize the epigenetic signature of PP, DP, and
neurons and its role in cortical development.
In recent years, epigenetic modiﬁcations have emerged as a key
mechanism regulating gene expression during differentiation of
embryonic and adult neural stem cells (Hirabayashi & Gotoh, 2010;
Smith & Meissner, 2013; Yao et al, 2016). Among these, modiﬁcation
of DNA, in particular cytosine methylation and hydroxymethylation,
was shown to be critical for cell fate change in the developing and
adult mammalian brain (Koh & Rao, 2013; Smith & Meissner, 2013;
Schubeler, 2015; Stricker & Go¨tz, 2018). For example, deletion of
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methyltransferases (Dnmt1 or 3a) impaired neuronal differentiation
resulting in a reduced number of neurons (Fan et al, 2005; Nguyen
et al, 2007; Wu et al, 2010). Similarly, manipulating the ten-eleven
translocation genes (Tet1 or 3), which encode enzymes oxidizing 5-
methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) driving
demethylation (Tahiliani et al, 2009; He et al, 2011), led to altered
corticogenesis (Hahn et al, 2013), neuronal death (Xin et al, 2015),
aberrant circuitry formation (Zhu et al, 2016), impaired adult
neurogenesis, and reduced cognitive performance (Kaas et al, 2013;
Rudenko et al, 2013; Zhang et al, 2013). However, as these attempts
to manipulate DNA methylation were limited to systemic genetic
deletions or pharmacological treatments causing genome-wide
changes, they failed to provide functional information with
regard to locus-speciﬁc effects. Moreover, current efforts to un-
derstand the dynamic changes in (hydroxy-)methylcytosine during
brain development have so far been limited to in vitro models of
neurogenesis or bulk tissues (Stadler et al, 2011; Hahn et al, 2013;
Lister et al, 2013; Mo et al, 2015; Ziller et al, 2015; Jaffe et al, 2016).
To ﬁll these gaps and decipher the role of DNA (de-)methylation
during brain development, systems are required that allow the (i)
identiﬁcation of 5mC and 5hmC (together referred to as 5(h)mC)
patterns in speciﬁc cell types, rather than whole tissues, during
neurogenesis and (ii) efﬁcient manipulation of DNA (hydroxy-)
methylation in a locus-speciﬁc, rather than systemic, manner for
which approaches with varying efﬁciency were recently described
(Liu et al, 2016; Morita et al, 2016). In this work, we achieved both
providing the ﬁrst cell type–speciﬁc resource of 5(h)mC patterns in
PP, DP, and neurons. This revealed that a commitment to neuro-
genesis in DP is characterized by an increase in 5hmC within en-
hancers of neurogenic genes and resulting in the subsequent loss
in 5mC in their neuronal progeny. We also found that these changes
correlated with the (i) acquisition of histone marks characteristic of
open chromatin, (ii) up-regulation and putative binding of basic
helix-loop-helix (bHLH) pioneer transcription factors, and (iii) ac-
tivation of their nearby neurogenic genes. Finally, we optimized the
use of dCas9-Tet1 to achieve the locus-speciﬁc manipulation of
(hydroxy-)methylation in developing mouse embryos and pro-
vided one example of the potential biological relevance of our
observations for one candidate 5(h)mC-dependent regulator of
neurogenesis involved in neurodevelopmental malformations
and mental retardation: Dchs1.
Results
Cell-speciﬁc assessment of 5(h)mC identiﬁes the bivalent
epigenetic signature of enhancers during neurogenic
commitment
To characterize the signature of DNA (hydroxy-)methylation during
corticogenesis, we FAC-sorted PP, DP, and neurons from Btg2RFP/
Tubb3GFP mice by their combinatorial expression of the two ﬂuo-
rescent reporters (RFP−/GFP−, RFP+/GFP−, and GFP+ irrespective of
RFP, respectively) (Aprea et al, 2013). Mice at the embryonic (E) day
14.5 were chosen as a stage at mid-corticogenesis, that is, when the
three cell types were similarly abundant. We next generated
genome-wide maps of both 5mC and 5hmC by adapting a com-
parative immunoprecipitation protocol (Tan et al, 2013) by which
DNA from different cell types were barcoded, mixed, and immu-
noprecipitated together considerably reducing experimental vari-
ability among samples. Antibodies against 5mC or 5hmC were used
and single-end sequencing performed in three biological replicates
(~35–60 million unique reads per sample) to cell-speciﬁcally assess
the (hydroxy-)methylome of each cell type (Figs 1A and S1A).
After assessing the quality and speciﬁcity of our immunopre-
cipitation (Fig S1B), we started to validate our approach by merging
together PP, DP, and neurons and comparing our data with previous
studies performed in cell cultures or bulk brain tissues (Hahn et al,
2013; Oda et al, 2006; Song et al, 2011; Tan et al, 2013; Wen & Tang,
2014). This conﬁrmed the general hyper- or hypo-(hydroxy-)
methylation state of previously reported individual loci, including
Xist, Hist1h2aa, Gapdh, Uchl1, and others, which in all cases showed
relative levels of 5(h)mC consistent with previous studies (Fig S1C
and D). Next, we assessed the genome-wide distribution of 5(h)mC
across gene bodies. In doing so, we also sought to investigate
a potential correlation among (hydroxy-)methylation patterns of
differentially expressed genes. Toward this, we selected from the
expression proﬁle of the same cell types previously reported by our
group (Aprea et al, 2013, 2015) the top 10% most highly or lowly
expressed genes (FPKM ≥ 2) and plotted the levels of 5(h)mC across
the two groups. This conﬁrmed the characteristic (Song et al, 2011;
Hahn et al, 2013) drop in 5(h)mC at the transcription start and end
sites (TSS and TES) (Fig 1B). In addition, we found that highly
expressed genes had lower 5mC levels speciﬁcally across their TSS
and the ﬁrst third of the gene body, whereas the inverse correlation
was found toward the 39 end (Fig 1B, top). A similar trend, but limited
to a smaller region within the TSS, was detected for 5hmC, whereas,
conversely, higher levels correlated with increased expression
across other regions of the gene body (Fig 1B, bottom) (similar
trends were also observed when analyzing individual cell types, not
shown).
Additional analyses of 5(h)mC patterns across several genomic
features, including exons, introns, CpG islands, and enhancers
(according to Ensembl annotation) of the E14.5 mouse revealed that
the most signiﬁcant enrichment in cytosine modiﬁcations, partic-
ularly 5hmC, occurred within enhancers (Fig 1C, note that in these
coverage-proﬁles, the variance was too small to be depicted). In-
terestingly, whereas these analyses pointed out the distribution of
5(h)mC within genomic features when pulling cell types together,
analysis of PP, DP, and neurons individually revealed a general
decrease in 5mC and increase in 5hmC during differentiation that
were particularly profound within enhancers relative to other re-
gions (Fig 1D and data not shown). Speciﬁcally, a loss in 5mC within
enhancers was primarily observed in the transition from DP to
neurons but not from PP to DP (Fig 1D, top), whereas a constant
increase in 5hmC was observed during neurogenic commitment
from PP to DP as well as from DP to neurons (Fig 1D, bottom).
Knowing that a gain in 5hmC by Tet enzymes is essential for active
demethylation at enhancers (Hon et al, 2014; Lu et al, 2014), this
suggested that the bivalent epigenetic signature within enhancers
of DP, with a gain in 5hmC but not yet a loss in 5mC, potentially
represented an initial step in the transition from high 5mC in PP and
its subsequent loss in neurons. This in turn implied that neurogenic
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Figure 1. Cell type–speciﬁc assessment of 5(h)mC.
(A) Drawing depicting the strategy of our study with PP, DP, and neurons (color coded in gray, red, and green, respectively, throughout all ﬁgures) FAC-sorted from
the E14.5 mouse cortex followed by DNA barcoding, mixture, immunoprecipitation, and sequencing. (B–D) Distribution and abundance (reads per million = RPM) of 5(h)mC
of the ±2,000-bp regions across gene bodies of the top 10% more highly or lowly expressed genes (B; thick and thin lines, respectively); genomic regions (C, as indicated);
or enhancers in PP, DP, and neurons (D, as indicated). Note that in this and all other ﬁgures, 5mC and 5hmC are consistently depicted as continuous (top) or
dashed (bottom) lines, respectively. Values for the three cell types were merged together (B, C) or depicted individually (D). Note the characteristic drop in 5(h)mC at the
TSS and TES (B) and the bivalent 5(h)mC signatures within enhancers during neurogenic commitment (D). Gray shadows in B represent the standard error of the
mean, which was too small to be visibly depicted in (C, D) because of the much higher number of loci in the latter relative to the former plots.
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commitment involves stage-speciﬁc, active remodeling of DNA
methylation at distal regulatory elements that may have escaped
previous analyses of bulk tissues or cell lines. In addition, our data
identiﬁed DP as a bivalent population deﬁned by levels of 5mC
similar to their precursors PP but intermediate in 5hmC between PP
and their neuronal progeny.
A concurrent loss in 5mC and gain in 5hmC occurs within, or in
proximity to, neurogenic genes up-regulated during fate
commitment
We then identiﬁed the loci whose 5(h)mC levels changed (±50%; P <
0.05) in speciﬁc cell types. Altogether, this led to ~25,000 differentially
(hydroxy-)methylated loci associated to 11,000 unique genes (nearest
TSS) in the PP-DP or DP-neuron transition (Fig 2A and Supplemental
Data 1 and 2).
Interestingly, our analysis showed that the number of loci losing
5mC (5mC-loss) during the PP-DP (1,927) or DP-neuron (3,716)
transition was overall 1.3- and 2.5-fold greater than the number of
loci undergoing the converse modiﬁcation and gain in 5mC (5mC-
gain: 1,475 and 1,463 for PP-DP and DP-neurons, respectively) (Fig 2A,
left: compare loss versus gain, orange and blue, respectively).
Concomitantly, a ~3.0- and 2.0-fold greater number of loci gained
5hmC (5hmC-gain) relative to those losing it (5hmC-loss) during
each cellular transition (4,757 versus 1,611 and 6.051 versus 3.043,
respectively) (Fig 2A, right: compare loss versus gain, orange and
blue, respectively). The trend andmagnitude of these changes were
reminiscent of the bivalent (hydroxy-)methylation signature of DP
within enhancers (Fig 1D) with the greatest loss in 5mC occurring
primarily during the DP–neuron transition, whereas an increase in
5hmC was similarly abundant during both transitions (Fig 2A). In
addition, the overall >2-fold greater abundance in 5mC-loss and
5hmC-gain loci relative to the conversemodiﬁcations (i.e., 5mC-gain
and 5hmC-loss) suggested a functional role for demethylation in
neurogenic commitment. However, these trends were insufﬁcient
to ascertain whether a loss in 5mC and gain in 5hmC occurred within
the same, rather than different, loci and, if so, whether changes
occurred at the level of the same, rather than different, cytosines.
To address the ﬁrst question, we selected 5hmC-gain loci at the
onset of neurogenic commitment in DP (4,757) and assessed within
these loci the changes in 5mC (Fig 2B). Conversely, we also tested
the inverse correlation after selecting all 5mC-loss loci in neurons
(3,716) and measuring within them the levels of 5hmC as before (Fig
2C). In both cases, we found a highly signiﬁcant (P < 1 × 10−20)
negative correlation both at the level of individual loci and mean
5(h)mC values (Fig 2B and C, heat and violin plots, respectively),
indicating that in the overwhelming majority of the cases, both
modiﬁcations occurred concomitantly within the same, 5mC-loss/
5hmC-gain, loci. Showing the speciﬁcity of these results, a much
weaker, if any, correlation was found among 5hmC-loss (1,611) and
5mC-gain (1,463) loci (Fig S2A and B), indicating that 5mC-loss/
5hmC-gain and 5mC-gain/5hmC-loss loci are functionally distinct.
We next selected six among this pool of 5mC-loss/5hmC-gain
loci, each containing 5–10 individual cytosines (48 in total) and
performed both bisulﬁte and oxidative bisulﬁte amplicon se-
quencing from genomic DNA of PP, DP, and neurons. This was
important not only to validate our (h)MeDIP analysis at single-
nucleotide resolution but also as a means to investigate whether
changes in 5(h)mC occurred at the level of the same cytosines
rather than different nucleotides within the same locus. For all six
loci, this not only validated the relative levels of 5(h)mC previously
assessed by (h)MeDIP but also showed that in essentially all cases
(44/48 cytosines; i.e., >90%), a 5mC-loss/5hmC-gain involved the
same cytosine residues in subsequent cellular transitions (three
examples are shown in Fig S2C). In addition, and conﬁrming pre-
vious results, the magnitude of the loss in 5mC from PP to DP, if any,
was typically minor (on average ~10%) and only became substantial
from DP to neurons (50% decrease), whereas the magnitude of a
gain in 5hmC was more robust and similar (twofold increase) in
both cellular transitions (Figs 2D and S2C).
To gain insight into the biological role of loci undergoing dif-
ferential (hydroxy-)methylation, we next investigated genes asso-
ciated with 5mC-loss/5hmC-gain loci (nearest TSS). Gene ontology
(GO) term analysis revealed a highly consistent and very strong
enrichment in neurogenesis-related terms, including as the top
three most enriched: neurogenesis, developmental process, and
cell signaling (Fig 2E). Highlighting the speciﬁcity of 5mC-loss/
5hmC-gain loci in neurogenic commitment, genes containing,
or in proximity to, loci undergoing the converse modiﬁcations of
5mC-gain/5hmC-loss showed less consistent terms with lower
enrichment scores and that in some cases were not even speciﬁc
for neuronal development, such asmesonephros development and
metabolism (Fig S2D). Finally, again taking advantage of the pre-
vious assessment of gene expression in PP, DP, and neurons of the
E14.5 mouse cortex (Aprea et al, 2013, 2015), we reconstructed the
expression levels of transcripts associated with 5mC-loss/5hmC-
gain loci ﬁnding a highly signiﬁcant up-regulation in the lineage
from PP to DP and reaching the higher expression levels in neurons
(Fig 2F). In turn, this indicated that 5hmC-gain alone correlated with
increased gene expression even before a loss in 5mC. Conversely,
no correlation was detected among genes associated with 5mC-
gain/5hmC-loss loci (Fig S2E).
Altogether, our study revealed the sequential molecular changes
in 5(h)mC in consecutive cell divisions during the neurogenic lin-
eage whereby hydroxymethylation is initiated at the onset of
fate commitment in DP and resulting in the subsequent loss in
methylation in their neuronal progeny. Such 5mC-loss/5hmC-gain
was more prevalent in loci annotated as enhancers and located
within, or in proximity to, neurogenic genes up-regulated during
differentiation, suggesting that active demethylation is a trigger of
neurogenesis and establishment of neuronal identity.
5mC-loss/5hmC-gain loci are enriched in active enhancers and
neurogenic pioneer factor–binding motifs
We next inspected the features of 5mC-loss/5hmC-gain loci. Ex-
tending our previous analysis at the genome-wide level (Fig 1D),
we also conﬁrmed among 5mC-loss/5hmC-gain loci a high en-
richment in Ensembl-annotated enhancers (average z-score 41.56;
P < 0.001). To investigate whether these enhancers were charac-
terized by an active chromatin state, we took advantage of the large
depository of ChIP-seq datasets provided by the Encyclopedia of
DNA Elements (ENCODE) (Shen et al, 2012). To this end, we overlaid
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our differentially (hydroxy-)methylated loci with that of histone
H3 lysine 27 acetylation (H3K27ac) and/or lysine 4 methylation
(H3K4me1) ChIP-seq data as signatures of active and poised en-
hancers, respectively (Mahe et al, 2017). By speciﬁcally selecting
data obtained from the E14.5 mouse cerebral cortex as equivalent
to our study, we found that 5mC-loss/5hmC-gain loci displayed a
sharp increase at their 59 and 39 end sites in H3K27ac as well as
H3K4me1 levels relative to both 5mC-gain/5hmC-loss and ran-
dom genomic loci (Figs 3A and S3A).
Given the strong correlation of 5mC-loss/5hmC-gain loci with
increased gene expression (Fig 2F) and enrichment in active en-
hancers (Fig 3A), we inspected whether these loci additionally
contained distinctive sequence motifs. We found a remarkably high
enrichment in binding motifs for hundreds of transcription factors
with the most signiﬁcant one belonging to the bHLH family and that
were very distinct from the binding motifs found within 5mC-loss/
5hmC-gain loci (Fig S3B, top ﬁve motifs). However, we noticed that
such a long list of bHLH transcription factors also included genes
that according to our previous transcriptome analysis of PP, DP, and
neurons (Aprea et al, 2013, 2015) were either expressed at negligible
levels at this developmental stage or not expressed at all (e.g.,
Bhlha15, Twist1, Atoh1, and others). This in turn suggested that
our motif enrichment analysis was confounded by the close
homology of bHLH binding sequences. Hence, to reinforce our
conﬁdence in the biological signiﬁcance of these ﬁndings, we
identiﬁed among the list of bHLH transcription factors those
speciﬁcally up-regulated in the PP–DP transition as a proxy for their
putative link with demethylation during neurogenesis. This led to
the selection of only six factors, including Neurod1-2, Neurog1-2,
Bhlh22, and Nhlh1 (Fig 3B), whose binding motifs ranked among the
top-20 most enriched speciﬁcally for 5mC-loss/5hmC-gain, but not
5mC-gain/5hmC-loss, loci (compare Figs 3C and S3C). Interestingly,
these six factors are known to play key roles in brain development
with both Neurod1 and Neurog2 being reported to act as pioneer
factors modifying the chromatin landscape during neurogenesis
(Pataskar et al, 2016; Smith et al, 2016). In turn, other factors in our
list were also shown to drive demethylation by association to Tet
enzymes (Donaghey et al, 2018; Sardina et al, 2018).
To provide an independent assessment of the putative binding
of at least some of these bHLH transcription factors within 5mC-
loss/5hmC-gain loci, we again took advantage of publicly available
ChIP-seq datasets. In mapping the reads obtained for two such
transcription factors, Neurod2 and Neurog2 (Bayam et al, 2015;
Velasco et al, 2017), within 5mC-loss/5hmC-gain loci as previously
carried out for histones marks, we indeed observed a strong
positive correlation that was absent when considering the converse
5mC-gain/5hmC-loss loci (Figs 3D and S3D). Conversely, we also
observed that a decrease in 5mC and increase in 5hmC occurred
at Neurod2 as well as Neurog2 binding sites (Fig 3E), further
strengthening our previous results.
Finally, we sought to provide one example and experimental
validation of the potential biological signiﬁcance of our observa-
tions and the role of (hydroxy-)methylation in controlling gene
expression of neurogenic genes during corticogenesis. To this aim,
we ﬁrst had to implement a method to site-speciﬁcally manipulate
5(h)mC in vivo.
An improved method to manipulate 5(h)mC reveals the role of
methylation within a novel regulatory element of Dchs1
To assess the biological relevance of our observations, we decided
to locus-speciﬁcally manipulate 5(h)mC by in utero electroporation
with an inactive (dead) dCas9 fused to the catalytic domain of Tet1
(dCas9-Tet1) (Fig 4A). To this aim, we generated an all-in-one vector
by adding to the dCas9-Tet1 construct a GFP as reporter and gRNAs
targeting the region of interest. Differently from two previous re-
ports, we decided to only use two gRNAs rather than several (Liu
et al, 2016) and avoid the bulky SunTag system to deliver Tet1
(Morita et al, 2016), thus decreasing potential off-targets and steric
hindrance at once.
To test the efﬁcacy and speciﬁcity of our system, we performed
electroporation of E13.5 mouse embryos and FAC-sorted GFP+ cells
48 h later (Fig 4A). Different control vectors were tested including a
dCas9 fused to a catalytically inactive dTet1 delivered together with
gRNAs against either an unspeciﬁc sequence (dCas9-dTet1LacZ) or
the target locus (dCas9-dTet1Target) with the latter control being
important to assess potential effects of dCas9 occupancy irre-
spective of Tet1 activity. Next, we selected four loci within regions
containing 4–9 CpG dinucleotides (28 in total) using as a main
criterion their high level of methylation (to increase the sensitivity
of our assessment) but not necessarily all the features emerging
from our analysis as characteristic of 5mC-loss/5hmC-gain loci.
Bisulﬁte amplicon sequencing on FAC-sorted GFP+ cells was then
used to assess methylation levels when using any of the three
vectors, that is, (i) inactive and unspeciﬁc dCas9-dTet1LacZ, (ii) in-
active but speciﬁc dCas9-dTet1Target, or (iii) both active and speciﬁc
dCas9-Tet1Target.
This revealed that although the levels of 5(h)mC appeared by all
means similar among the two control vectors when averaging
cytosines within the target region together (Fig 4B), the use of the
inactive but speciﬁc dCas9-dTet1Target was still sufﬁcient to induce
several signiﬁcant, and in some instances inconsistent, changes at
Figure 2. 5mC-loss/5hmC-gain loci characterize neurogenic genes up-regulated during fate commitment.
(A) Volcano plots depicting the loss (orange) and gain (blue) in 5mC (left) or 5hmC (right) from PP to DP and DP to neurons (as indicated). Number of signiﬁcantly
(>50% change, P < 0.05) differentially (hydroxy-)methylated loci (top) and nearest genes (parentheses) are indicated. (B, C) Heat maps (left) and violin plots (right)
representing 5(h)mC levels within a ±2-kb region across differentially (hydroxy-)methylated loci in each cell type (colors, as above) calculated as log2(ChIP/control) or
trimmed mean of M values (TMM), respectively. In this analysis, 5hmC-gain and 5mC-loss loci identiﬁed in DP (4,757) or neurons (3,716), respectively, were ﬁrst
taken as a reference (top panels) and the levels of the converse cytosine modiﬁcation (i.e., 5mC or 5hmC for B and C, respectively) measured within these very same loci
(bottom) revealing the extensive correlation in 5(h)mC changes. (D) Whiskers–box plots of 5mC and 5hmC levels (left and right, respectively) calculated for
individual cytosines (n = 48) after (oxidative) bisulﬁte amplicon sequencing of six among all 5mC-loss/5hmC-gain loci (one examples of which is depicted in Fig S2C).
Data are plotted as fold change relative to PP. (E, F) DAVID-gene ontology term enrichment (top three terms) (E) and expression levels (FPKM) (F) of 5mC-loss and
5hmC-gain loci in the PP–DP and DP–neuron transitions (as indicated). Note the high enrichment, speciﬁcity, and consistency of the GO terms and the highly signiﬁcant
change in gene expression throughout the neurogenic lineage. Statistical test = edgeR-modiﬁed t test (A), Wilcoxon rank sum test (B, C, D and F).
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Figure 3. 5mC-loss/5hmC-gain loci are enriched in active enhancers and pioneer factor–binding motifs.
(A) Distribution and abundance (RPM) of active enhancer marks including H3K27ac (left) or H3K4me1 (right) as depicted across a ±1-kb region of loci undergoing
differential (hydroxy-)methylation. For these plots, all eight possible combinations were considered, namely, gain (thick lines) or loss (thin lines) in 5mC (left) or 5hmC
(right) in the PP–DP (black/red lines) or DP–neuron (red/green lines) transition as well as random loci as negative controls (blue lines). Note the increase in both
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the level of individual cytosines (Fig S4A), which were likely due to
dCas9 occupancy of the target locus irrespective of Tet1 activity. In
contrast, only the active and speciﬁc dCas9-Tet1Targetwas found to
induce a signiﬁcant, major, and consistent reduction (~90%; P <
0.001) in methylation of the entire locus and across essentially all
CpG dinucleotides (Figs 4B and S4A) but not affecting those within
~20 bp of the dCas9-binding region or outside (e.g., CpG 1 and 8 in
Fig S4A, top left). While assessing the effects in (hydroxy-)
methylation within the four target loci in embryos electroporated
with active dCas9-Tet1Target constructs, we also assessed 5(h)mC
of the remaining three loci ﬁnding no signiﬁcant change relative
to dCas9-dTet1LacZ controls (not shown) and validating both the
efﬁciency and speciﬁcity of our approach.
We next veriﬁed the suitability of the previous control vectors to
assess neurogenesis by comparing the distribution of electro-
porated cells in cortical layers 48 h after electroporation at E13.5
relative to an empty GFP control. Hence, we calculated the pro-
portion of apical and basal progenitors and neurons by Tbr2 im-
munoreactivity and distribution of GFP+, electroporated cells
across cortical layers (Tbr2− in the VZ, Tbr2+ in the VZ/SVZ, and
Tbr2− in the IZ and CP, respectively). Unexpectedly, we found that
electroporation with dCas9-dTet1LacZ had a minor, yet signiﬁcant,
increase in GFP+, apical progenitors and equivalent decrease in
neurons, which was particularly noticeable in the CP relative to
both GFP and active, but unspeciﬁc, dCas9-Tet1LacZ control vectors
(Fig S4B). This was surprising because the dCas9-dTet1LacZ vector
did not encode any functional protein, its effect onmethylation was
overall minor and inconsistent (Fig 4B), and a previous study using a
similar vector did not report any negative effect on neurogenesis
(Morita et al, 2016).
To gain more insight into this unexpected result, we repeated
electroporation using only dTet1 vectors without dCas9 or gRNAs to
exclude potential side effects of the former and off-targets of the
latter. Once again, dTet1 alone triggered a subtle but signiﬁcant
change in the proportion of GFP+ cells, which was similar to the one
previously observed using dCas9-dTet1LacZ constructs (Fig S4B).
These subtle changes in any condition in which constructs
encoding dTet1 were used resembled those previously reported in
cell culture for the very same catalytically inactive enzyme (Gao
et al, 2016) and suggested to result from dTet1 interaction with
Gadd45a, a gene involved in neural development (Kienhofer et al,
2015). Therefore, considering the caveats arising from the use of
dTet1 vectors, we concluded that dCas9Target was a superior neg-
ative control that, contrary to empty vectors such as GFP, still
accounts for potential side effects due to dCas9 occupancy and
hindrance of the target locus.
Having established our approach, we next sought to provide one
example of the potential biological relevance of our observations
on differential (hydroxy-)methylation during neurogenic commit-
ment by targeting a 5mC-loss/5hmC-gain locus. To this aim, we
selected candidates among target regions that epitomized all the
key features emerging from our study including: (i) a 5mC-loss/
5hmC-gain in DP, (ii) within, or in proximity to, genes containing
Neurod2 and Neurog2 binding motifs, and (iii) whose nearby gene
was physiologically up-regulated during fate commitment. Among
these, as expected from our previous gene ontology enrichment
analysis (Fig 2E), we found numerous markers and characterized
regulators of neurogenesis such as Emx1, Prox1, Eomes, Pou4f1, Dll3,
Tcf4, Tubb3, Wnt members, and others. We ﬁnally selected Dchs1
because of its relatively recent identiﬁcation as a novel gene
controlling the proliferation of neural progenitors and whose
mutations is cause of developmental malformations, including
heterotopia, in Van Maldergem syndrome (Cappello et al, 2013).
Beyond this, and as one additional advantage of choosing Dchs1 as
a target for manipulation, its differential (hydroxy-)methylation
occurred within a locus predicted, but not validated, to act as an
enhancer that we sought to simultaneously assess by our exper-
iments. In particular, this relatively tiny, 300-bp putative enhancer
within an intron of a complex gene >35 kb in length and comprising
23 exons (Fig 4C, top) was of doubtful signiﬁcance making it for a
particularly challenging target to test our method and biological
signiﬁcance of our observations on (hydroxy-)methylation.
Hence, after conﬁrming the differential (hydroxy-)methylation
physiologically occurring within the Dchs1 locus in PP, DP, and
neurons by bisulﬁte sequencing (not shown), we designed dCas9-
Tet1Dchs1, or dCas9Dchs1 as control constructs that were used to
electroporate E13.5 mouse embryos. FAC-sorting of GFP+ cells 48 h
later followed by bisulﬁte sequencing conﬁrmed, also in this ad-
ditional case, the efﬁcacy of our approach leading to an overall
~50% decrease in 5(h)mC relative to control (Fig 4C). In these
experiments, we additionally assessed potential off-targets of
dCas9-Tet1Dchs1 and dCas9Dchs1 within the 10 genomic regions
having the highest homology to the Dchs1 gRNAs (5 each). Bisulﬁte
amplicon sequencing of all these regions revealed no signiﬁcant
change in methylation at the level of all loci as well as individual
cytosines (Fig 4D and data not shown), again highlighting the high
speciﬁcity of our approach. Next, we investigated whether or not a
loss inmethylation alone was sufﬁcient to change the expression of
Dchs1 by performing qRT–PCR on GFP+ FAC-sorted cells, which
resulted in a 2.5-fold up-regulation of Dchs1 relative to control (Fig
4E). Importantly, this result conﬁrmed three assumptions at once:
(i) it validated the regulatory function of the predicted enhancer
within Dchs1, (ii) it showed that differential (hydroxy-)methylation
within a 5mC-loss/5hmC-gain locus is a cause, rather than conse-
quence, of gene up-regulation, and (iii) it showed that demethylation
alone can potentially account for the observed up-regulation in
histone marks sharply at the 59 and 39 end of 5mC-loss/5hmC-gain, but not 5mC-gain/5hmC-loss, loci (heat maps are also shown in Fig S3A to appreciate
individual loci). ChIP-Seq data for H3K27ac and H3K4me1 from the E14.5 mouse cortex were taken from the ENCODE project (Shen et al, 2012). Shadows represent the
variance (SD) of the mean that in some cases was too small to be visibly depicted. (B, C) Expression levels (FPKM) of bHLH transcription factors up-regulated from
PP to DP (B), and enrichment values of their binding motifs within 5mC-loss/5hmC-gain loci (C) (top ﬁve motifs are shown in Fig S3B). (D) Distribution and abundance
(RPM) of Neurod2 and Neurog2 ChIP-Seq reads across a ±1-kb region including loci undergoing any of the eight possible combinations of differential (hydroxy-)
methylation depicted as in A and including random loci as negative control (variance was too small to be depicted). (E) Converse analysis as in (D) with
distribution and abundance (RPM) of 5(h)mC reads of PP (black), DP (red), N (green) plotted across Neurod2 (left)– and Neurog2 (right)–binding sites (bold) and random
regions as negative control (left and right; thin lines).
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Figure 4. Site-speciﬁc manipulation of (hydroxy-)methylation.
(A) Drawing depicting dCas9-Tet1 targeting of a locus of interest through the use of two gRNAs (yellow) to manipulate 5(h)mC at CpG dinucleotides (black circles)
by in utero electroporation (right) of a vector including all components of interest plus GFP as reporter. (B)Whiskers–box plots depicting 5(h)mC levels of FAC-sorted GFP+
cells 48 h after in utero electroporation as assessed by bisulﬁte sequencing of 48 cytosines within four loci (individual loci and values are shown in Fig S4A). Note
the major reduction in 5(h)mC upon use of dCas9-TetTarget constructs. (C) Screenshot of 5(h)mC levels in cell types (left) and drawing (in scale) of the Dchs1 locus
and regions targeted by dCas9-TetDchs1 vectors (top). Assessment of 5(h)mC in GFP+ cells 48 h after in utero electroporation was performed as described in Figs 4B and S4A
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Dchs1 during neurogenesis because the magnitude of the change
induced by dCas9-Tet1Dchs1 (2.5-fold) was nearly identical to that
occurring from PP to neurons in physiological conditions (2.2-fold)
(Aprea et al, 2013).
Moreover, as mentioned above, down-regulation of Dchs1 was
described to increase progenitor proliferation and alter neuronal
migration (Cappello et al, 2013). Hence, we ﬁnally assessed whether
a converse up-regulation of Dchs1 by targeted demethylation
would reach the levels that are necessary to trigger a biological
effect consistent with this previous report. Indeed, immunohisto-
chemistry 48 h upon electroporation at E13.5 with dCas9-Tet1Dchs1
and EdU administration 6 h before sacriﬁce showed a 30% de-
crease (from 37.4 ± 3.5 to 25.4 ± 3.5%; P < 0.001) in proliferation and
EdU+/GFP+ cells relative to dCas9Dchs1, control vectors (Fig 4F).
Moreover, BrdU birthdating 24 h before sacriﬁce revealed that the
migration of newborn neurons was also impaired with a sub-
stantial, threefold increase (from 4.3 ± 2.3 to 17.7 ± 5.2%; P < 0.001) in
the proportion of BrdU+/GFP+/Tbr2− (i.e., excluding basal pro-
genitors) cells in the SVZ and their altered distribution in medial
bins of the IZ, neuronal layer (Fig 4G).
Altogether, the observed decrease in proliferation of progenitors
and altered neuronal migration induced by demethylation-driven
up-regulation of Dchs1 were consistent with a previous report
(Cappello et al, 2013) and showed that demethylation within this
newly identiﬁed regulatory region of Dchs1 alone is both sufﬁcient
to trigger its up-regulation to the levels observed in physiological
conditions and necessary to produce a biological effect.
Discussion
Regulation of DNA (hydroxy-)methylation in stem cells and its role
in controlling gene expression during fate commitment have been
the focus of many studies resulting in conﬂicting hypotheses with
regard to the causes underlying these changes (Calo & Wysocka,
2013; Smith & Meissner, 2013; Schubeler, 2015; Atlasi & Stunnenberg,
2017). Here, we provided the ﬁrst resource describing the patterns of
5mC and 5hmC in speciﬁc cell types of the developing mammalian
cortex. We further relate this to the gene expression program
underlying speciﬁcation of distinct cell fates during cortical de-
velopment. We found that a switch from proliferative to neuro-
genic divisions was characterized by a gain in 5hmC in DP followed
by a loss in 5mC in newborn neurons. These changes occurred
predominantly within regions annotated as enhancers and en-
riched in pioneer transcription factor–binding motifs, which ul-
timately correlated with up-regulation of their nearby neurogenic
genes. We then assessed the potential biological signiﬁcance
of our observations by developing an improved method to site-
speciﬁcally manipulate 5(h)mC in vivo. By this, we identiﬁed a
novel regulatory element within a factor involved in cortical
malformations: Dchs1. Several aspects of our study are worth
discussing.
First, and contrary to our study, a previous description of the
(hydroxy-)methylome of mixed populations of progenitors versus
neurons did not observe a loss in 5mC during neurogenesis (Hahn
et al, 2013). This inconsistency is likely explained not only by our
discrimination of PP and DP as distinct cell populations but also
by the higher resolution of our sequencing analysis relative to the
microarrays previously used. In addition, Hahn et al (2013) used
MIRA as a method to detect 5mC, which strongly favors its
identiﬁcation within CpG islands despite the fact that our and
previous studies (Guo et al, 2011; Schubeler, 2015; Yao et al, 2016)
have shown that CpG islands are not target of differential (hy-
droxy-)methylation. As a result, by also considering DP as an
intermediate cell type with a bivalent epigenetic signature, our
study reveals the full dynamics of cytosine modiﬁcations that
may be critical to decipher the role of this epigenetic mark in
corticogenesis.
Second, we found that a gain in 5hmC is initiated in DP resulting
in a loss in 5mC in their neuronal progeny. These 5mC-loss/5hmC-
gain loci (i) occurred within, or in close proximity to, neurogenic
genes, (ii) were enriched in binding motifs of bHLH, among them
pioneer, transcription factors, and (iii) their change in (hydroxy-)
methylation correlated with an activation of enhancers and up-
regulation of gene expression. Notably, these genes included
many known regulators and markers of corticogenesis, such as
Emx1, Prox1, Eomes, Dll3, Tcf4, Tubb3, Wnt family members, and
Dchs1, to mention a few, which in essentially all cases were up-
regulated in the PP–DP–neuron lineage. In describing the features
of 5mC-loss/5hmC-gain loci, we also observed that the converse
pair of cytosine modiﬁcations, namely, 5mC-gain/5hmC-loss,
consistently displayed unrelated characteristics such as a di-
verse enrichment in genomic features, transcription factor–
binding motifs, and so forth. This does not imply that these latter
modiﬁcations are irrelevant in neurogenesis as in fact, several
sites among this group were adjacent to positive regulators of
stemness and pluripotency. For example, a gain in 5mC was ob-
served at loci for Nanog, Shh, Numb, Pou3f2, and others and
whose expression decreased in the PP-DP transition consistent
with a functional role during differentiation. In addition, 5mC-gain
loci showed an enrichment in binding motifs for methylation-
sensitive transcription factors and negative regulators of neu-
rogenesis such as Hif1a and Hes1 (Koslowski et al, 2011; Yin et al,
2017). As such, our data highlight that a gain in 5mC and loss in
5hmC, although still important, are uncoupled from each other
and controlled independently through mechanisms yet to be
identiﬁed.
Third, in addition to providing an improved method for dCas9-
mediated manipulation of (hydroxy-)methylation, we assessed the
signiﬁcance of our observations by validating the causal link
(bottom). (D) Whiskers–box plots depicting 5(h)mC levels assessed by bisulﬁte sequencing at top 10 predicted off-target regions (5 for each gRNA, 51 CpGs total) of
FAC-sorted GFP+ cells 48 h after in utero electroporation of dCas9-TetDchs1 or dCas9Dchs1. (E) Dchs1 expression levels (ΔΔCT) calculated by qRT–PCR on GFP+ cells as
described in (C). Note the ~2.5-fold increase expression upon demethylation. (F, G) Pictures of the E15.5 mouse cortex (left) and quantiﬁcations (right) 24 h after
electroporation under different conditions followed by (immuno-)labeling for GFP, EdU, or BrdU (as indicated). Boundaries of the SVZ with the VZ and IZ were assessed by
Tbr2 staining (not shown) or equidistant bins through the IZ are indicated (dashed lines in E and F, respectively) in which GFP+ cells were expressed as proportion
of their total number. Scale bar = 50 μm; bars = SD (SEM in C); n ≥ 6 (E and F); statistical test = t test; *P < 0.05; **P < 0.01; ***P < 0.001.
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between demethylation, up-regulation of gene expression, and
regulation of corticogenesis for one paradigmatic gene containing a
5mC-loss/5hmC-gain locus: Dchs1. This gene has recently emerged
as a novel regulator of brain development whose mutations cause
Van Maldergem syndrome, an autosomal-recessive disorder char-
acterized by intellectual disability and skeletal malformations
(Cappello et al, 2013). In fact, knockdown of Dchs1 in the developing
cortex was shown to cause heterotopia as a result of an increased
cell proliferation and delayed neurogenesis (Cappello et al, 2013),
which is consistent with our converse manipulation leading to
increased expression of Dchs1, reduced proliferation and altered
neuronal migration. Although the previously identiﬁed Dchs1 mu-
tations causing heterotopia result in a truncated protein (Cappello
et al, 2013), it is here intriguing to consider the possibility that other
developmental malformationsmay involve cytosine residues target
of (hydroxy-)methylation and resulting in aberrant gene expression.
Such a role of DNA modiﬁcations in disease is supported by the
observation that methylated cytosines are hotspots for single-
nucleotide polymorphisms (Schubeler, 2015) and changing the
methylation of even one single cytosine residue may result in
changes in expression levels (Furst et al, 2012). In this context, it is
worth mentioning that our manipulation of Dchs1 led to a reduction
by roughly half in methylation of just eight CpG dinucleotides within
a small region of a relatively big, multiexonic gene. It is thus re-
markable that this alone was sufﬁcient to double the expression of
Dchs1 to levels similar to those observed during physiological
differentiation. Therefore, the recent possibility to recapitulate
(hydroxy-)methylation patterns in human iPS-derived organoids
(Luo et al, 2016) combined with their site-speciﬁc manipulation
opens up a new dimension in studying the role of epigenetics in
diseases of the brain and other organs.
Finally, fourth, our data are in line with recent observations
pointing out that the binding of pioneer transcription factors per
se can cause demethylation (Donaghey et al, 2018; Sardina et al,
2018). In fact, at least for the transcription factors identiﬁed in our
study, their expression was speciﬁcally increased in DP and,
hence, became more abundant in the appropriate cell type and at
the appropriate time for initiating hydroxymethylation. In addi-
tion, although DNA binding of transcription factors is generally
inhibited by methylation, these bHLH pioneer factors are meth-
ylation insensitive (Yin et al, 2017) and, thus, display the appro-
priate feature needed to initiate and drive this process. In light
of this, a model has been recently reviewed in which pioneer
transcription factors drive the activation of enhancers (Atlasi &
Stunnenberg, 2017). Our data are consistent with this model
and would even extend it in the context of DNA demethylation
which, together with changes in histone marks and opening of
the chromatin, concur toward the activation of enhancers, up-
regulation of nearby neurogenic genes and, hence, cell fate
change (Fig 5). The bivalent (hydroxy-)methylation footprint of DP
is also fully consistent with this model and suggests a dual
function to ﬁrst, fate-commit DP to switch from proliferative to
neurogenic division and second, to consolidate neuronal identity
in the resulting neurons. This is reminiscent and would actually
explain the reported onset of expression of neuron-speciﬁc genes
already at the level of DP (Aprea et al, 2013) as if this cell type was
primed to acquire the early features of their future neuronal
progeny. Clearly, key aspects of this model are still highly debated
such as whether DNA methylation is a cause or a consequence of
gene up-regulation and cell fate change (Stricker & Go¨tz, 2018). At
least for Dchs1, our study shows that demethylation alone can be
a driver of these processes.
Figure 5. DNA (hydroxy-)methylation in neurogenic commitment.
A model emerging from several studies (see text) suggests that pioneer transcription factors (PTFs) drive cell fate commitment and differentiation by remodeling
chromatin. In this context, our data suggest that PTF up-regulated during the PP–DP transition are associated with oxidation of 5mC to 5hmC (black to blue dots) within
enhancers of neurogenic genes. This results in priming of those genes (dotted to continuous arrow) and fate commitment of DP toward neurogenic division. This
process is continued during the next cell division (DP-N) leading to higher levels of 5hmC, reinforced gene expression (continuous to bold arrow), and establishment of
neuronal identity despite a possible down-regulation of PTF.
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Materials and Methods
Animals and cell sorting
Mice were kept under standard housing conditions, and experi-
ments were carried out according to local regulations. E14.5
Btg2RFP/Tubb3GFP double heterozygous embryos or E13.5 C57bl/6J
pregnant mice (Janvier Laboratories) were used for (h)MeDIP or in
utero electroporation, respectively. For the latter, the mice were
treated as previously described (Aprea et al, 2013) by injecting
~3 μg of endotoxin-free DNA into the telencephalic ventricles
followed by delivery of eight 50-ms-long electric pulses of 36 V
with intervals of 1 s. The mice were euthanized 48 h later even-
tually upon intraperitoneal administration of 1 mg BrdU (1 pulse at
E14.5) and/or 0.1 mg EdU (3 and 6 h before sacriﬁce). Brains were
either dissected and processed for immunohistochemistry or
dissociated by the papain-based neural dissociation kit (Milteney
Biotec). FAC-sorting was performed at 4°C in the four-way purity
mode with a ﬂow rate of 20 μl/min and side and forward scatter
light to eliminate debris and aggregates gating for green (488 nm)
and red (561 nm) ﬂuorescence as described (Aprea et al, 2013). The
cells were sorted into DNA/RNA lysis buffer (QIAamp DNA Micro,
QIAGEN or Quick-RNA MicroPrep Zymo Research) or pelleted
(500 g, 5 min at 4°C) for later use.
(h)MeDIP and sequencing
Comparative 5(h)mC immunoprecipitation ((h)MeDIP) was adapted
from Tan et al (2013). Brieﬂy, 1 µg of DNA from PP, DP, or neurons in
three independent biological replicates was sheared using the
Covaris LE220 (duty cycle 10%, intensity 5, cycles/burst 200, 180 s)
into ~250 bp fragments that were ligated to barcoded sequencing
adaptors (NEBNext Ultra DNA Library Prep kit for Illumina; New
England Biolabs). 300 ng of DNA from each cell type was pooled and
(h)MeDIP performed using the MagMeDIP or hMeDIP kits (Diagnode)
according to the manufacturer instructions. The immunopre-
cipitated DNA and non-antibody–treated control was quantiﬁed,
ampliﬁed (15 cycles; NEBNext High-Fidelity 2X PCR Master Mix;
New England Biolabs), gel size selected (225–325 bp) using the
E-Gel EX system (2%) (Invitrogen), and used for 75-bp single-read
sequencing on an Illumina HiSeq 2000 platform resulting in ~30–60
million reads per sample. Sequencing raw data were deposited in
Gene Expression Omnibus (GEO) database: GSE104585.
Bioinformatics and statistics
Raw sequencing reads were aligned to the mm10 reference ge-
nome using BWA v0.7.8 and peaks called using SICER v1.1 (window =
25 bp, gap = 50 bp, fragment = 250 bp, max redundant reads = 2, and
FDR = 0.0001). Peaks found in all replicates of each cell type were
merged to build a reference peak sets of PP, DP, and neurons
for 5mC and 5hmC excluding those overlapping repetitive se-
quences (RepeatMasker). Diffbind v2.6 was used to calculate TMM
(DBA_SCORE_TMM_READS_EFFECTIVE) values and identify differ-
ential (hydroxyl-)methylated regions (DBA_edgeR, 50% change, P <
0.05) that were annotated using HOMER v4.7. Genomic features, GO
terms, or enrichment of transcription factor–binding motifs were
assessed by HOMER v4.7, DAVID v6.8, or MEME-AME v5.0 (JASPAR
CORE and UniPROBE mouse), respectively. ChIP-seq data from the
ENCODE or GEO databases were used to generate bigwig ﬁles
calculating the log2(control/ChIP) using deepTools v3.0.2 (bin
size = 50, scaling method = SES) that was also used together with
NGSplot v2.61 (robust statistics fraction = 0.05) to generate proﬁle
plots or heat maps, respectively. Off-targets of gRNAs were pre-
dicted using Cas-OFFinder (http://www.rgenome.net/cas-ofﬁnder/).
Z-scores were calculated using regioneR (1.14.0) permutation test
(n = 1,000). Bar and whiskers–box plots were built using RStudio
v1.0.143 and t test, or Wilcoxon rank sum test was used to assess
signiﬁcance as appropriate.
Constructs
The dCas9-Tet1 fusion protein with a 9–amino acid linker
(LQGGGSGS) was generated by replacing the DNMT3a domain within
pdCas9-DNMT3A-EGFP (Vojta et al, 2016) with the active or inactive
catalytic domain of human TET1 (Maeder et al, 2013) with cassettes
being introduced (Table S1) for one (LacZ) or two gRNAs under
independent U6 promoters. The (d)Tet1 cassette was removed by
enzymatic digestion (FseI/XhoI) to obtain the dCas9 control
plasmid.
Immunohistochemistry
Immunohistochemistry was performed as described (Aprea et al,
2013). Brieﬂy, the brains were ﬁxed in 4% paraformaldehyde in 0.1 M
phosphate buffer (pH 7.4; PFA) at 4°C for 12 hours, cryoprotected in
30% sucrose, and cryosectioned (10 μm). Sodium citrate (0.01 M; pH
6.0)–based antigen treatment was performed (1 h at 70°C) followed
by incubation with the appropriate antibodies (Table S2), washes
with PBS, and PFA post-ﬁxation for 30 min. For EdU, the Click-iT
Alexa Fluor 647 kit was used according to the manufacturer’s in-
structions (Invitrogen). For BrdU, the sections were incubated in 2 M
HCl after post-ﬁxation for 30 min at 37°C, followed by washes with
PBS and antibody incubation.
(Oxidative-)bisulﬁte amplicon sequencing and qRT–PCR
(ox)BSamp-seq protocol was adapted from Masser et al (2015).
Brieﬂy, 0.2–1 μg of DNA was converted either using the EpiTect
Bisulﬁte kit (QIAGEN) for BSamp-seq or the TrueMethyl-seq kit
(Cambridge Epigenetix) for oxBSamp-seq. Converted DNA was used
as a template to PCR-amplify the region of interest using bisulﬁte-
speciﬁc primer pairs (Table S1). The purity and size of the amplicons
was validated on gels and puriﬁed using the QIAquick PCR Puri-
ﬁcation Kit (QIAGEN). 0.2 μM from all amplicons of each sample were
pooled and used for tagmentation-based whole-genome library
preparation using the Nextera DNA Library Preparation Kit (Illu-
mina). Libraries were ampliﬁed using the KAPA High Fidelity Master
Mix (PeqLab), puriﬁed using Ampure XP-beads (Beckman& Coulter),
and loaded on a Miseq-Nanoﬂowcell (Illumina). Each sequencing
run resulted in about 100,000 reads distributed over all pooled
amplicons. Data were analyzed using Bismark 0.16.0. For qRT–PCRs,
reverse transcription was performed with 30–100 ng of RNA using
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the iScript cDNA Synthesis kit (Bio-Rad). Transcripts were quantiﬁed
by iQ SYBR Green Supermix (Bio-Rad) on a CFX Connect real-time
PCR Detection System (Bio-Rad) using the appropriate primers
(Table S1).
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201900331.
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